Steven Cohen's STRO Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 692,111 shares of Sutro Biopharma, Inc. (STRO) worth $17.24 M, representing 0.02% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in STRO, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 513,023 shares. Largest reduction occurred in Q1 2025, reducing 219,754 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Sutro Biopharma (STRO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Sutro Biopharma (STRO) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +513,023 | Add 286.46% | 692,111 | $24.91 |
| Q4 2025 | +179,088 | New Buy | 179,088 | $11.57 |
| Q1 2025 | -219,754 | Sold Out | 0 | $0.00 |
| Q4 2024 | -79,991 | Reduce 26.69% | 219,754 | $18.40 |
| Q3 2024 | -145,018 | Reduce 32.61% | 299,745 | $34.60 |
| Q2 2024 | +418,693 | Add 1606.03% | 444,763 | $29.30 |
| Q1 2024 | -2,500 | Reduce 8.75% | 26,070 | $56.50 |
| Q4 2023 | -24,745 | Reduce 46.41% | 28,570 | $42.90 |
| Q3 2023 | +32,415 | Add 155.10% | 53,315 | $34.70 |
| Q2 2023 | +20,900 | New Buy | 20,900 | $46.50 |
| Q1 2023 | -79,060 | Sold Out | 0 | $0.00 |
| Q4 2022 | +7,960 | Add 11.20% | 79,060 | $80.80 |
| Q3 2022 | +71,100 | New Buy | 71,100 | $55.50 |
| Q4 2021 | -37,500 | Sold Out | 0 | $0.00 |
| Q3 2021 | -76,160 | Reduce 67.01% | 37,500 | $188.91 |
| Q2 2021 | +17,840 | Add 18.62% | 113,660 | $185.90 |
| Q1 2021 | -45,111 | Reduce 32.01% | 95,820 | $227.60 |
| Q4 2020 | +39,881 | Add 39.47% | 140,931 | $217.10 |
| Q3 2020 | +41,050 | Add 68.42% | 101,050 | $100.49 |
| Q2 2020 | +60,000 | New Buy | 60,000 | $77.60 |
| Q3 2019 | -32,238 | Sold Out | 0 | $0.00 |
| Q2 2019 | +32,238 | New Buy | 32,238 | $113.81 |
Steven Cohen's Sutro Biopharma Investment FAQs
Steven Cohen first purchased Sutro Biopharma, Inc. (STRO) in Q2 2019, acquiring 32,238 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Sutro Biopharma, Inc. (STRO) for 22 quarters since Q2 2019.
Steven Cohen's largest addition to Sutro Biopharma, Inc. (STRO) was in Q1 2026, adding 692,111 shares worth $17.24 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 692,111 shares of Sutro Biopharma, Inc. (STRO), valued at approximately $17.24 M.
As of the Q1 2026 filing, Sutro Biopharma, Inc. (STRO) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Sutro Biopharma, Inc. (STRO) was 692,111 shares, as reported at the end of Q1 2026.